509 related articles for article (PubMed ID: 16515464)
1. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
2. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids and their involvement in the neurovascular system.
Battista N; Fezza F; Maccarrone M
Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
7. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid amide hydrolase: a potential target for next generation therapeutics.
Maccarrone M
Curr Pharm Des; 2006; 12(6):759-72. PubMed ID: 16472164
[TBL] [Abstract][Full Text] [Related]
9. Critical enzymes involved in endocannabinoid metabolism.
Basavarajappa BS
Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
[TBL] [Abstract][Full Text] [Related]
10. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid regulation in human endometrium across the menstrual cycle.
Scotchie JG; Savaris RF; Martin CE; Young SL
Reprod Sci; 2015 Jan; 22(1):113-23. PubMed ID: 24819878
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
[TBL] [Abstract][Full Text] [Related]
13. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
Fezza F; De Simone C; Amadio D; Maccarrone M
Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
Ueda N; Tsuboi K; Uyama T; Ohnishi T
Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid metabolic pathways and enzymes.
Ligresti A; Cascio MG; Di Marzo V
Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system in ageing: a new target for drug development.
Paradisi A; Oddi S; Maccarrone M
Curr Drug Targets; 2006 Nov; 7(11):1539-52. PubMed ID: 17100593
[TBL] [Abstract][Full Text] [Related]
20. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]